New Radiopharmaceutical Markers for Metabolism and Receptor
Fig. 9.1 18F-FACBC positive bone metastases in high-risk prostate cancer at staging evaluation. A 71-year-old patient diagnosed with high-risk prostate cancer (PSA 6.8 ng/ml; cT2; GS 4 + 4) underwent…